OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know
Wioleta M. Zelek, R. A. Harrison
Immunobiology (2023) Vol. 228, Iss. 3, pp. 152393-152393
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Pathophysiology of Disseminated Intravascular Coagulation in Sepsis: A Clinically Focused Overview
Ahsanullah Unar, Lorenzo Bertolino, Fabian Patauner, et al.
Cells (2023) Vol. 12, Iss. 17, pp. 2120-2120
Open Access | Times Cited: 21

Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects
Е. Л. Насонов
Rheumatology Science and Practice (2024) Vol. 62, Iss. 1, pp. 32-54
Open Access | Times Cited: 5

Single-cell and spatial transcriptomics illuminate bat immunity and barrier tissue evolution
Roy Levinger, Dafna Tussia-Cohen, Sivan Friedman, et al.
Molecular Biology and Evolution (2025)
Open Access

Functional mass spectrometry indicates anti-protease and complement activity increase with COVID-19 severity
Douglas D. Fraser, Swapan Kumar Roy, M. Kuruc, et al.
Experimental Biology and Medicine (2025) Vol. 250
Open Access

Complement is primarily activated in the lung in a mouse model of severe COVID-19
Peter J. Szachowicz, Christine Wohlford-Lenane, Cobey J. H. Donelson, et al.
iScience (2025) Vol. 28, Iss. 3, pp. 111930-111930
Open Access

Escalated complement activation during hospitalization is associated with higher risk of 60‐day mortality in SARS‐CoV‐2‐infected patients
Andreas Barratt‐Due, Kristin Pettersen, Tuva Børresdatter‐Dahl, et al.
Journal of Internal Medicine (2024) Vol. 296, Iss. 1, pp. 80-92
Open Access | Times Cited: 4

Cutting-Edge Techniques and Drugs for the Treatment of Pulmonary Embolism: Current Knowledge and Future Perspectives
Lorenzo Falsetti, Emanuele Guerrieri, Vincenzo Zaccone, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1952-1952
Open Access | Times Cited: 4

Aprotinin (II): Inhalational Administration for the Treatment of COVID-19 and Other Viral Conditions
Juan Fernando Padín, José Manuel Pérez‐Ortiz, Francisco Javier Redondo Calvo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7209-7209
Open Access | Times Cited: 3

Parallel electrophysiological abnormalities due to COVID‐19 infection and to Alzheimer's disease and related dementia
Yang Jiang, Jennifer Watling Neal, Pradoldej Sompol, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 3

The complement system: A key player in the host response to infections
Archana Jayaraman, Sarah Walachowski, Markus Bosmann
European Journal of Immunology (2024) Vol. 54, Iss. 11
Open Access | Times Cited: 2

Complex changes in serum protein levels in COVID-19 convalescents
Smruti Pushalkar, Shaohuan Wu, Shuvadeep Maity, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

Circulating mortalin in blood and activation of the alternative complement pathway as risk indicators in COVID-19 infection
Maya Avraham, György Sinkovits, Lisa Hurler, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1

Epidemiological Study in Antiviral Innate Immunity
Xiaoyu Zhao, Yuting Liu, Ruogu Cheng, et al.
Methods in molecular biology (2024), pp. 189-197
Closed Access | Times Cited: 1

Optimizing the use of vilobelimab for the treatment of COVID-19
Matthew W. McCarthy
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 9, pp. 877-881
Closed Access | Times Cited: 4

Intravenous immunoglobulin as a potential treatment for long COVID
Matthew W. McCarthy
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 12, pp. 1211-1217
Closed Access | Times Cited: 4

Screening, Synthesis and Biochemical Characterization of SARS-CoV-2 Protease Inhibitors
Martynas Bagdonas, Kamilė Čerepenkaitė, Aurelija Mickevičiūtė, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13491-13491
Open Access | Times Cited: 2

A New Approach to Analyze the State of the Complement System in Patients with COVID-19. Pilot Study
П. П. Авдонин, Lidia A. Komleva, Maria S. Blinova, et al.
Биологические мембраны Журнал мембранной и клеточной биологии (2024) Vol. 41, Iss. 2, pp. 139-148
Closed Access

The future of complement therapeutics
Martin Kolev, Kollu N. Rao, Michael W. Yeh, et al.
Exploration of Immunology (2024), pp. 577-615
Open Access

Immunity and Coagulation in COVID-19
П. П. Авдонин, Maria S. Blinova, Anastasia A. Serkova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11267-11267
Open Access

Proteomic signatures of vaccine-induced and breakthrough infection-induced host responses to SARS-CoV-2
Erin Williams, Felipe Echeverri Tribin, Juan Manuel Carreño, et al.
Vaccine (2024) Vol. 43, pp. 126484-126484
Closed Access

Patterns of C1-Inhibitor Plasma Levels and Kinin–Kallikrein System Activation in Relation to COVID-19 Severity
Silvia Berra, Debora Parolin, Chiara Suffritti, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1525-1525
Open Access

Quantitative IgG response to SARS-CoV-2 membrane protein in infected individuals strongly correlates with lung injury
Giovanni Faggioni, Filippo Moramarco, Eugenio Luciano, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access

Anaphylatoxin signaling activates macrophages to control intracellular Rickettsia proliferation
Mustapha Dahmani, Jinyi C. Zhu, Jack H. Cook, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top